This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 11 May 2016  |  Asia Pacific

    Asia-Pacific Telehealth Market Outlook, Forecast to 2020

    Shifting Cost and Consumer Trends to Support Innovative Delivery Models Driven by mHealth, Remote Patient Monitoring and Telemedicine

    Healthcare industry challenges including aging populations, rising incidence of chronic diseases, and the need to manage care costs better are necessitating the adoption of innovative care delivery models. While healthcare providers and consumers are displaying a perceivable behavior shift in the way they interact with health technologies, vendors ...

    $4,950.00
  2. 18 Apr 2016  |  Asia Pacific

    Asia-Pacific Healthcare Outlook, 2016

    Clinical Wearables, Regenerative Medicines and Biosimilars Set for Strong Growth

    Demand for healthcare services will continue to grow in Asia-Pacific (APAC) under the influence of demographic and epidemiological transitions impacting the entire region. APAC governments which shoulder the largest burden of paying for healthcare services will take decisive steps to innovate their healthcare systems in order to face future challen...

    $4,950.00
  3. 18 Apr 2016  |  Africa

    Africa Healthcare Industry Outlook, 2016

    Value-based Transformations in Home Diagnostic Technologies, Exclusive Drugs, and Improved Point of Care Energise Healthcare Ecosystem

    Africa is experiencing a plethora of changes in the healthcare segment. From being the market of imports and low-value manufacturing, the continent is transforming into a region of tailor-made medical equipment that is compatible with telemedicine solutions. There is an increase in the in-country production of pharmaceuticals, smart phone applicati...

    $4,950.00